Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| LianBio | 325,901 | reported | 29 Mar 2023 | tx 4+1,025,534 |
| Olema Pharmaceuticals, Inc. | 29,500 | reported | 18 Jun 2026 | tx 9+188,023 |
| Turning Point Therapeutics, Inc. | 7,321 | reported | 08 Feb 2021 | tx 18+403,011−60,000 |
| RayzeBio, Inc. | 0 | reported | 26 Feb 2024 | tx 3−114,579 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Jun 2026 | GRANT_AWARD | Olema Pharmaceuticals, Inc. | 29,500 | 0.00 USD | deriv |
| 11 Jun 2025 | GRANT_AWARD | Olema Pharmaceuticals, Inc. | 24,150 | 0.00 USD | deriv |
| 14 Jun 2024 | GRANT_AWARD | Olema Pharmaceuticals, Inc. | 23,000 | 0.00 USD | deriv |
| 26 Feb 2024 | OTHER | RayzeBio, Inc. | 14,332 | — | deriv |
| 26 Feb 2024 | OTHER | RayzeBio, Inc. | 59,399 | — | deriv |
| 26 Feb 2024 | OTHER | RayzeBio, Inc. | 40,848 | — | deriv |
| 16 Jun 2023 | GRANT_AWARD | Olema Pharmaceuticals, Inc. | 21,520 | 0.00 USD | deriv |
| 29 Mar 2023 | GRANT_AWARD | LianBio | 325,901 | 0.00 USD | |
| 20 Jan 2023 | GRANT_AWARD | LianBio | 464,099 | 0.00 USD | deriv |
| 16 Jun 2022 | GRANT_AWARD | Olema Pharmaceuticals, Inc. | 21,520 | 0.00 USD | deriv |
| 01 Dec 2021 | GRANT_AWARD | LianBio | 5,996 | 0.00 USD | deriv |
| 31 Oct 2021 | GRANT_AWARD | LianBio | 229,538 | 0.00 USD | deriv |
| 09 Jun 2021 | GRANT_AWARD | Olema Pharmaceuticals, Inc. | 21,520 | 0.00 USD | deriv |
| 05 Apr 2021 | GRANT_AWARD | Olema Pharmaceuticals, Inc. | 3,773 | 0.00 USD | deriv |
| 05 Apr 2021 | GRANT_AWARD | Olema Pharmaceuticals, Inc. | 21,520 | 0.00 USD | deriv |
| 08 Feb 2021 | GRANT_AWARD | Turning Point Therapeutics, Inc. | 4,617 | 0.00 USD | |
| 08 Feb 2021 | GRANT_AWARD | Turning Point Therapeutics, Inc. | 20,775 | 0.00 USD | deriv |
| 02 Feb 2021 | SALE | Turning Point Therapeutics, Inc. | 4,574 | 129.80 USD | |
| 02 Feb 2021 | SALE | Turning Point Therapeutics, Inc. | 7,267 | 130.58 USD | |
| 02 Feb 2021 | SALE | Turning Point Therapeutics, Inc. | 1,057 | 131.73 USD | |
| 01 Feb 2021 | EXERCISE | Turning Point Therapeutics, Inc. | 15,702 | 54.03 USD | |
| 01 Feb 2021 | SALE | Turning Point Therapeutics, Inc. | 4,783 | 122.94 USD | |
| 01 Feb 2021 | SALE | Turning Point Therapeutics, Inc. | 8,576 | 123.70 USD | |
| 01 Feb 2021 | SALE | Turning Point Therapeutics, Inc. | 2,143 | 124.60 USD | |
| 01 Feb 2021 | SALE | Turning Point Therapeutics, Inc. | 200 | 126.07 USD |